has served as a consultant and receives research support from Ironwood Pharmaceuticals
doi: 10.1111/obr.12266, 114 Pi-SunyerX.AstrupA.FujiokaK.GreenwayF.HalpernA.KrempfM.et al
During this time, participants may need to attend clinic visits, follow a treatment schedule, and keep a health journal
Pastoris, O., Dossena, M., Foppa, P., Catapano, M., Arbustini, E., Bellini, O., Dal Bello, B., Minzioni, G., Ceriana, P., and Barzaghi, N
The platform states that OpenLoop Health clinicians "retain the decision to prescribe compounded GLP-1s to patients" and have "established exclusionary criteria to determine if an individual does not qualify for GLP-1s." Safety and Eligibility Considerations According to MEDVi's eligibility requirements, users must meet the following criteria: Be at least 18 years of age Reside in the United States in a state where services are available Agree to provide complete and accurate health information The company's terms acknowledge that "provision of Healthcare Services through the Platform depends on the completeness and accuracy of Your Information" and that "MEDVi is unable to verify all of Your Information." General GLP-1 Safety Considerations: GLP-1 receptor agonists carry potential side effects that vary by individual
Adults and senior care includes careful monitoring of all medicines and health changes